Background and Purpose-Despite the importance of exercise training in mitigating cardiovascular risk, the development of exercise programs for people poststroke has been limited by lack of feasibility data concerning cardiopulmonary exercise testing (CPET) to inform the exercise prescription. Therefore, we examined the feasibility of CPETs for developing an exercise prescription in people Ն3 months poststroke. Methods-CPET results from 98 consecutively enrolled patients poststroke with motor impairments and 98 age-and sex-matched patients with coronary artery disease were examined at baseline and after 6 months of exercise training. Results-The proportion of patients with stroke and coronary artery disease attaining an intensity sufficient for prescribing exercise at baseline was 68.4% versus 82.7%, respectively (Pϭ0.02) and 84.7% versus 83.8% (Pϭ0.9) at 6 months. Women were less likely than men poststroke to achieve a sufficient intensity at baseline (40% versus 80.9%, PϽ0.001) but not at 6 months (78.3% versus 87.1, Pϭ0.3). A clinically relevant abnormality occurred in 11.2% of stroke and 12.2% of patients with coronary artery disease on baseline CPETs (Pϭ0.8) and 10.6% of stroke and 5.9% of patients with coronary artery disease on the 6-month CPET (Pϭ0.4). No serious cardiovascular events occurred during 349 CPETs. Key Words: electrocardiography Ⅲ rehabilitation Ⅲ stroke care Ⅲ stroke delivery Ⅲ stroke recovery D espite exercise being an important component of stroke rehabilitation, there is a dearth of information on the clinical use and feasibility of cardiopulmonary exercise testing (CPET) for individuals with a history of stroke before engaging in exercise. This issue merits special attention in view of the growing recognition of the importance of exercise in the secondary prevention of stroke and the risk of comorbid coronary artery disease (CAD).
D
espite exercise being an important component of stroke rehabilitation, there is a dearth of information on the clinical use and feasibility of cardiopulmonary exercise testing (CPET) for individuals with a history of stroke before engaging in exercise. This issue merits special attention in view of the growing recognition of the importance of exercise in the secondary prevention of stroke and the risk of comorbid coronary artery disease (CAD).
CPETs are not routinely administered before starting a cardiac rehabilitation (CR) program after stroke. 1 Consequently, exercise is often prescribed without an objective assessment of the patients' functional capacity, resting and exercise blood pressures, exercise-related symptoms, and/or electrocardiographic (ECG) changes including dysrhythmias. 2 Despite recommendations to base exercise prescriptions on CPET results, few data are available to substantiate the feasibility and safety of graded exercise tests with ECG monitoring after stroke. 3 Lacking this information has hindered the development of exercise programs tailored to the functional capacities of survivors of stroke.
A CPET involves measuring oxygen uptake, carbon dioxide output, and minute ventilation at the same time as monitoring blood pressure and 12-lead ECG. Measures derived from the CPET guide the activity attributes of the exercise prescription. From both a safety and efficacy point of view, the most important parameter of the prescription is that of intensity. 4 -6 Intensity of exercise is believed to be the primary factor responsible for change in peak oxygen uptake (VO 2peak ) 6, 7 and a higher VO 2peak is associated with lower stroke risk in males 8 as well as lower mortality in cardiac patients. 5 Moreover, evidence that the intensity of physical activity (moderate to high) may be a greater determinant of stroke prevention than duration of exercise is accumulating. 9, 10 In view of the importance of exercise intensity, an exercise prescription based on objective measures derived from a CPET is important. The CPET determines the ventilatory anaerobic threshold (VAT), which represents the movement from aerobic to anaerobic metabolism, 11 and is recommended as an appropriate target intensity level for the prescription of exercise. [12] [13] [14] Achievement of maximal oxygen uptake (VO 2max ; ie, an individual's maximal capacity to transport and use oxygen) is another important measure used to prescribe exercise intensity. Therefore, VO 2max , VAT, and the level at which a clinically relevant abnormality (CRA) occurs are all critical measures for prescribing an exercise intensity that is both safe and effective. However, people who have had a stroke may be limited by a constellation of motor and neurological impairments that may prevent them from reaching these critical levels. These issues may discourage the systematic application of CPETs for individuals after stroke. Accordingly, the objective of this study was to examine the feasibility of the CPET for developing an exercise prescription for patients with chronic stroke (Ն3 months poststroke with no upper limit) with motor impairments. We speculated that most patients (Ͼ50%) would reach a level of exertion that would provide information for exercise prescription with no serious cardiovascular events (death, myocardial infarction, or sustained ventricular tachycardia).
Methods
This was a retrospective analysis of CPETs conducted at baseline and after 6 months of exercise training in 98 consecutively enrolled patients in Toronto Rehabilitation Institution's Risk Factor Modification and Exercise Program following Stroke (TRI-REPS; Figure  1 ). The TRI-REPS program is a substream of the CR program modeled after the traditional CR program. A comparison group of 98 age-and sex-matched patients consecutively enrolled in the CR program who had a documented history of CAD and no history of stroke or transient ischemic attack were included. Patients in both cardiac and stroke services attended 90-minute exercise classes once per week for 6 months and were offered baseline and follow-up (6-month) CPETs. To test our hypothesis, we calculated the proportion of patients who achieved VO 2max , VAT, or a CRA that would prohibit an exercise prescription beyond the intensity where it occurred on the baseline and 6-month CPETs.
Subjects
To be admitted to the TRI-REPS program, patients had to be Ն3 months poststroke (no upper limit) with a stroke-related motor impairment score Ͻ7 on the Chedoke-McMaster Stroke Assessment scale of the arm, hand, leg, or foot (described subsequently). In addition, patients had to be able to ambulate Ն10 meters independently with or without an assistive device with no significant limitations due to pain and no contraindications to maximal exercise testing 15 such as a recent significant change in the resting ECG, symptomatic severe aortic stenosis, uncontrolled resting severe hypertension, or uncontrolled metabolic disease such as diabetes. Higher functioning patients were integrated into the regular CR program and were not included in the analysis. Patients in the CAD cohort had a documented history of CAD (myocardial infarction, angiographic evidence showing Ն50% stenosis in Ն1 major coronary artery, percutaneous coronary intervention, or coronary artery bypass graft surgery, and were referred Ն6 weeks since coronary artery bypass graft surgery or myocardial infarction or Ն3 weeks since percutaneous coronary intervention. The study was approved by the institution's Research Ethics Board.
Poststroke Baseline Assessments
Motor recovery stage of the arm, hand, leg, and foot of the strokeaffected side was classified on the 7-point Chedoke-McMaster Stroke Assessment scale. 16 A Chedoke-McMaster Stroke Assessment scale motor impairment score of 1 indicates flaccid paralysis, 3 describes marked spasticity and weakness, 6 indicates near normal coordination of patterns of movement and no spasticity, and 7 describes normal movement. 16 Patients performed the 6-minute walk test 17 walking as far as possible over a 30-meter course in 6 minutes.
Baseline Characteristics
At entry to CR, individuals poststroke had a similar cardiovascular risk factor profile when compared with patients with CAD ( Table 1) . Fewer patients with stroke than patients with CAD were prescribed ␤-blockade medications (PϽ0.001). Most individuals after stroke had a history of ischemic stroke (70.4%), used a gait aide for ambulation (59.2%), and 93.9% had a motor impairment score between 3 (marked spasticity) and 6 (near normal coordination of movement) of the leg on the 7-point Chedoke-McMaster Stroke Assessment scale ( Table 2 ). The 6-minute walk test distance at baseline represented 52.3%Ϯ27% of predicted norms. 18 CPETs were conducted in 98 patients with stroke and 98 patients with CAD at baseline and 85 patients with stroke and 68 patients with CAD after 6 months of training. A greater proportion of patients in the CAD cohort discontinued the CR program than in the stroke cohort (30% versus 13%, Pϭ0.001). Most baseline CPETs were conducted on the upright cycle for patients with CAD (78.6%) and on the recumbent cycle for individuals after stroke (50%; Supplemental Table I ; http://stroke.ahajournals.org).
Cardiopulmonary Exercise Test
CPETs were conducted in all patients at baseline and 6 months except in those who prematurely discontinued the CR program. A resting 12-lead ECG, medical history, and anthropometric measures were collected before each CPET. The test was conducted by 2 cardiopulmonary exercise technicians under the direct supervision of 1 physician. A CPET on either a recumbent cycle ergometer with specialized pedals to secure feet (Ergoline Select 1000), an upright cycle (Ergoselect 200P), or a treadmill was performed. The type of ergometer and testing protocol was chosen by the testing staff based on balance and control of leg/foot position on the pedal. None of the testing modalities required exertion of the upper body. Individuals poststroke who had excessive hemiparetic hip weakness had their leg stabilized by an elastic band looped around the thighs. Workload was increased by either 8.3 or 16.7 W every minute at a pedaling rate of 60 rpm, the aim being to achieve test durations of between 8 and 12 minutes. Breath-by-breath gas samples were collected and averaged over a 20-second period through a calibrated metabolic cart (SensorMedics Vmax Encore) with continuous monitoring of 12-lead ECG (Marquette Case 80), and blood pressure. Indications for discontinuing CPET were peak volitional effort (ie, if the patient was unable to maintain the required pedaling rate), the appearance of adverse clinical signs or symptoms as described elsewhere, 15 or if the patient achieved VO 2max (described subsequently). The expected VO 2peak (mL ⅐ kg Ϫ1 ⅐ min Ϫ1 ) was calculated from established age and sex norms 19 for comparison of cardiopulmonary fitness across age and sex.
Exercise Prescription and Progression
Participants in both stroke and cardiac streams of the CR program attended once-weekly, 90-minute supervised sessions of aerobic and resistance training with the balance of exercise conducted offsite (4 additional aerobic training and 1-2 additional resistance training sessions). The staff-to-patient ratio of the TRI-REPS program was higher than the traditional cardiac program (1:5 versus 1:12, respectively). All exercise sessions were tracked by individual exercise diary. The mode of aerobic training and type of resistance training exercises were prescribed depending on individual ability. The aerobic training goal for both cohorts was to progress patients to 20 to 60 minutes of exercise 3 5 times ⅐ week Ϫ1 . 20 For patients with CAD, the aerobic training prescription was set at an intensity equivalent to 40% to 80% of VO2 peak 15 and/or the level at which the VAT occurred. 12 Patients were given a target distance and duration to complete. Prescriptions were progressed every 2 weeks to a maximum of 6.4 km and then to a maximum intensity of 80% of VO 2peak as tolerated. Initial exercise intensity for individuals after stroke considered a combination of the following: the heart rate achieved at the VAT; 40% to 70% of heart rate reserve; and the heart rate that occurred at 40% to 70% of VO 2peak . 3 Exercise diary information, heart rates measured at the center as well as communication with the patient assisted the case manager in deciding when to increase the intensity and/or duration of the aerobic training exercise. 20 For both cohorts, the intensity of the initial prescription and subsequent exercise was adjusted to achieve a rating of perceived exertion of 11 to 16 ("light" to "hard") 15 on the Borg 6 to 20 scale. 21 The CAD cohort was prescribed an resistance training routine of 10 exercises targeting the lower body (3 exercises), upper body (5 exercises), and the trunk (2 exercises) as described elsewhere. 22 For the stroke cohort, the choice and number of resistance training exercises were based on the patients' goals, gait pattern, grip strength, joint range of motion, presence or degree of hypertonicity, and balance. The exercises were task-specific, incorporating muscle actions that are performed during daily activities, emphasizing retraining of balance, coordination, body weight support, weight shifting, and incorporating multijoint movements. Resistance was provided by handheld dumbbells, exercise bands (wrist/ankle attachments), or patients' body weight. A weight load equivalent to 50% to 60% of 1 repetition maximum was prescribed on the nonaffected limb. On the hemiparetic limb, Ն50% of 1 repetition maximum and/or a resistance rated as 13 to 14 on the rating of perceived exertion scale on the last repetition of the set was prescribed. 23 Patients in both cohorts gradually progressed from 1 to 2 sets and then from 10 to 15 repetitions and then increased resistance by 1.6 to 5 kg or increased the exercise band level and then reduced repetitions to 10 and repeated this process.
Criteria to Determine Feasibility of CPET for Exercise Prescription
To determine if the CPET provided adequate information to develop an effective exercise prescription, at least 1 of the 3 following intensity levels had to be attained on the CPET: (1) Maximal oxygen uptake, that is, VO 2max ; (2) VAT; and (3) a CRA that would prohibit an exercise prescription beyond the intensity where it occurred (see subsequently). VO 2max and VAT were determined by 2 independent assessors experienced in threshold analysis blinded to either the objectives of the study or patient diagnoses. Disagreements were resolved by consensus. The first criterion, VO 2max , was determined based on attainment of Ն1 of the following: (1) an oxygen uptake plateau at the end of the CPET defined as an increase of Ͻ2.1 mL ⅐ kg Ϫ1 ⅐ min Ϫ1 of oxygen 24 for Ն60 seconds despite an increase in work rate concomitant with a respiratory exchange ratio of Ն1.15 25 ; or (2) an respiratory exchange ratio of Ն1.15 concomitant with a peak heart rate within 10 beats/min of age-predicted maximum defined by the formula 220-age (years) 26 or using the validated equation (HR max ϭ 164 -0.7ϫage) 27 for patients taking ␤-blockade medication.
The second criterion, the VAT, was determined by a combination of the V-slope method and the ventilatory equivalents methods. 28, 29 The V-slope method was defined as the point of departure from linearity of carbon dioxide output plotted against oxygen uptake. The ventilatory equivalent method was defined as the level corresponding to the rise in ventilatory equivalent of oxygen that occurs without a concurrent rise in the ventilatory equivalent of carbon dioxide. The VAT is considered a valid measure demonstrating high reproducibility and low interobserver variability when established standards are followed. 30, 31 Finally, CRA criteria were defined as abnormalities that would prohibit exercise beyond the intensity where it occurred, indicating increased risk of an acute cardiac event or elevated mortality risk.
These included the appearance of horizontal or downsloping STsegment depression of Ն0.10 mV (1 mm) 80 ms past the J point on the ECG 15 , angina pectoris or chest pain developed with exertion, or complex or high-grade ventricular arrhythmia (frequent multiform ventricular premature beats (Ն3 in 10 beats), runs of ventricular tachycardia (Ն3 consecutive ventricular premature beats), 15 or exercise-induced bundle branch block).
Patients in both cohorts who had a CRA on the CPET underwent an ECG telemetry with blood pressure monitoring during the first exercise session (walking on a 200-meter track or stationary cycling) to establish a safe exercise intensity (ie, below the level where the CRA occurred). Modifications to the exercise program to reduce risk of a CRA during exercise such as including a longer cardiovascular warm-up, taking nitroglycerin before exercise, and exercising close to the time of peak effect of ␤-blockade medication was prescribed.
Safety
Serious cardiovascular events were defined as death, myocardial infarction, sustained ventricular tachycardia lasting Ͼ30 seconds, syncope, cardiopulmonary arrest, or a clinical condition necessitating cardiopulmonary resuscitation.
Results
The proportion of CPETs that provided information sufficient to prescribe exercise intensity (ie, VO 2max , VAT, or a CRA) for the stroke and CAD groups was 68.4% versus 82.7%, respectively (Pϭ0.02) at baseline and 84.7% versus 83.8% respectively (Pϭ0.9) at 6 months (Table 3; Figure 2) .
A CRA was observed in 11.2% and 12.2% of baseline CPETs conducted in patients with stroke and CAD, respectively (Pϭ0.8). This included 7 of 67 patients poststroke (10.5%) with no documented history of CAD and 4 of 31 patients poststroke (12.9%) with a documented history of CAD. A CRA occurred at 6 months in 10.6% (nϭ9) of patients with stroke and 5.9% (nϭ4) of (Pϭ0.4) patients with CAD. Of individuals poststroke with no history of CAD, 10.3% (6/58) had a CRA, and of those with a documented history of CAD, 11.7% had a CRA (3/27) at 6 months.
Significantly fewer individuals poststroke achieved VO 2max at baseline than those with CAD (Pϭ0.003) but at 6 months, there was no significant difference (Pϭ0.3). A greater proportion of persons with stroke versus CAD discontinued the CPET owing to noncardiovascular reasons at baseline (Pϭ0.007) with no significant difference at 6 months between groups (Pϭ0.9; Supplemental Table II) .
No serious cardiovascular events occurred during 183 CPETs conducted in persons after stroke and in 166 persons with CAD.
Sex Differences
Women poststroke were significantly less likely than men poststroke (40% versus 80.9%, respectively, PϽ0.001) and less likely than women with CAD (80%, Pϭ0.002) to reach Ն1 of the critical levels used for determining exercise prescription (Figure 3 ). There was no significant sex difference in proportion of CRAs on the baseline CPET or any further sex differences in proportion reaching VO 2max , VAT, or a CRA on the 6-month CPET.
Baseline sex differences for patients after stroke are presented in Tables 1 and 2 . Women entered CR at a higher stage of motor recovery than men of the leg and foot (both Pϭ0.006). Women reached a significantly lower baseline peak VO 2peak than men after stroke (52.1%Ϯ20.8% versus 67.9%Ϯ26.3% of age-and sex-predicted normative values, Pϭ0.005) and compared with women after CAD (72.6%Ϯ16.7%, PϽ0.001). Women after stroke were significantly more likely to discontinue the baseline CPET owing to noncardiovascular reasons than men (33% versus 11.8%, Pϭ0.01) including discomfort with the equipment (nϭ6), weakness in 1 leg (nϭ3), and leg pain (nϭ1). At 6 months, there were no significant differences in VO 2peak between women and men poststroke (68.6%Ϯ20.1% versus 78.3%Ϯ29.7% of age-and sex-predicted normative values, Pϭ0.2) but differences in noncardiovascular reasons for discontinuing the CPET remained (16.7% versus 3.2% of women and men, respectively, Pϭ0.047).
Discussion
We have demonstrated herein that most patients after stroke achieve exercise intensities sufficient to inform the exercise prescription on both baseline and 6-month CPETs. In addition, no serious cardiovascular events occurred during graded exercise to peak effort. However, although most women after stroke were able to reach a suitable intensity for exercise 
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prescription on the 6-month CPET, less than half of the baseline CPETs were of adequate intensity for exercise prescription determination. Indeed, women after stroke were more disadvantaged than both men poststroke and women post-CAD regarding baseline CPET use. Age, type of stroke, time from stroke, stage of motor recovery, gait aid requirement, modality of testing, or frequency of CRAs did not explain the mitigated use when compared with men poststroke. Rather, reduced baseline CPET use may, in part, be explained by the marked deconditioning in women after stroke at entry to CR. VO 2peak was half of normative values and significantly lower compared with men after stroke and women with CAD. This may have accounted for women's reduced ability to reach VO 2max or VAT because more highly conditioned patients are more likely to attain maximal levels on a CPET 32 and VAT is increasingly more likely to be determined in patients who attain a higher VO 2peak . 31 Although there is a paucity of data on sex differences in functional outcomes poststroke, data from the Framingham Heart Study show that prestroke and poststroke disability and rates of institutionalization are significantly higher in women than men. 33 Although motor recovery stage was higher for women than men in the present study, there may be functional differences that were not reflected by the Chedoke-McMaster Stroke Assessment scale score and not measured in this study, which may have also accounted for the poorer baseline performance in women. The finding that there was a preponderance of noncardiovascular barriers that more frequently prevented women in reaching peak effort than men, including weakness and discomfort in 1 leg and intolerance of the exercise testing equipment, may be a reflection of greater disability. Nevertheless, after 6 months of exercise training, use of the CPET for women poststroke was similar to men poststroke and equal to women with CAD. In view of the superior CR completion rate of stroke compared with patients with CAD, it is unlikely that this improvement can be explained by selective dropout. Rather, improved CPET use from baseline may be due, in part, to gains in cardiovascular fitness on the 6-month test that placed women at a similar cardiovascular fitness level (age and sex normative values) to both men after stroke and to women with CAD. Survivors of stroke have a physiological disadvantage compared with individuals after CAD because they exhibit muscle atrophy in the hemiparetic limb 34 contributing to quadriceps muscle weakness. 35 Although sex differences in vascular and muscle morphology poststroke have not been fully elucidated, a program of aerobic and resistance training may have mitigated these affects allowing women to reach a higher intensity on the 6-month CPET. Indeed, greater leg strength has been shown to be associated with a higher VO 2peak in patients with CAD. 23 The improved cardiovascular fitness and ability of women to reach higher absolute intensity levels on the CPET after a program of resistance and aerobic training is of clinical significance given the disability and institutionalization rates in women poststroke. 33 Combined with greater life expectancy and later onset of stroke in women compared with men 33, 36 indicates the growing importance of developing strategies to improve the feasibility of the initial CPET to inform exercise programming for women. In the interim, a CPET conducted midprogram (ie, 3 months from start) may provide valuable information for prescribing exercise.
CPETs may involve risks for patients after stroke in view of the high incidence of CAD and associated risk factors. However, no serious cardiovascular events occurred during 183 graded exercise tests to peak effort. Nevertheless, Ͼ1 in 10 patients after stroke demonstrated a significant abnormality that would prohibit exercise beyond the intensity where it occurred on both baseline and follow-up CPETs. In addition, these abnormalities occurred equally in those with and without a comorbid history of CAD. Moreover, the rate of clinically relevant abnormalities was equal to that of patients in the CAD cohort at both time points despite reaching a significantly lower CPET intensity (35% versus 73% of ageand sex-predicted maximal heart rate, respectively). Thus, it is possible that the rate of abnormality is underrepresented in the stroke cohort in this study. Other studies using coronary angiography or thallium scintigraphy suggest a higher rate of abnormality in patients after stroke. 37, 38 Limitations CR programs offer multiple CPET modality options as well as the experience and training to assess and manage patients with multiple comorbidities that may not exist in other facilities. Therefore, findings in this study may not be generalizable to all facilities or to all individuals poststroke referred to an exercise program, including those early in stroke recovery. Although the VAT has been reported to be modality-specific, almost half of patients with stroke were prescribed a stationary cycle program either alone or in combination with a walking program. Finally, angiographic or perfusion imaging in patients with stroke who exhibited abnormalities on the CPET is lacking.
Conclusions
The results of this study support the feasibility and use of systematically conducting CPETs for those with chronic stroke both with and without CAD comorbidity before engaging in exercise. Prescription methods without this information may risk an exercise intensity that does not provide adequate cardiovascular stress to induce a training response or may precipitate a cardiovascular issue. At least 1 in 10 individuals poststroke manifested a clinically relevant abnormality on stress testing that would require exercise modification; however, there were no serious cardiovascular events during CPET or CR. With appropriate adaptation of exercise test protocols, most patients can achieve adequate exercise levels and cardiac safety issues can be identified. In view of the mitigated use of the baseline CPET for prescribing exercise to women after stroke, strategies to identify and remove barriers that limit women in reaching these critical intensities require further investigation. 
